Перьета (Perjeta)
(pertuzumab)
(420 mg)
(one)
(Концентрат)
Perjeta (pertuzumab) 420 mg, generic, India
In Stock
Perjeta is indicated for use in combination with trastuzumab and docetaxel in adult patients with HER2-positive metastatic or locally recurrent unresectable breast cancer who have not previously received anti-HER2 therapy or chemotherapy for metastatic disease.
-
Commercial name:Перьета (Perjeta)
-
Сhemical name:pertuzumab
-
Dosage:420 mg
-
Quantity:one
-
Release form:Концентрат
-
Производитель:Zudys, Индия
No reviews yet